Label Value
DOI 10.1038/bjc.2015.322
TITLE A serum metabolomic fingerprint of bevacizumab and temsirolimus combination as first-line treatment of metastatic renal cell carcinoma
TYPE article
PUBLICATION DATE
Service Status Date Last Checked
Scopus Yes 2018-02-12T11:52:52.004357
Web of Science Yes 2018-04-08T18:24:38.078417
Compendex No 2019-12-19T03:44:59.960943